Patients on artificial pancreas show better glucose control

12/26/2013 | Family Practice News

A study presented at the World Diabetes Congress revealed adolescent type 1 diabetes patients who used a closed-loop continuous glucose monitoring system attained lower mean glucose levels and fewer nocturnal hypoglycemia incidents compared with those who used sensor-augmented pump therapy. Patients who used the artificial pancreas also had more time in blood glucose targets than the sensor-augmented pump arm, researchers noted.

View Full Article in:

Family Practice News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA